Literature DB >> 12213946

IgA nephropathy.

James V Donadio1, Joseph P Grande.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12213946     DOI： 10.1056/NEJMra020109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  223 in total

1.  Children are not small adults.

Authors:  Heather Dean; Elizabeth Sellers; Patricia Birk; Tom Blydt-Hansen; Malcolm Ogborn
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

2.  Clinical remission of Henoch-Schönlein purpura nephritis after a monotherapeutic tonsillectomy.

Authors:  Yoshitaka Iwazu; Tetsu Akimoto; Shigeaki Muto; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2010-09-09       Impact factor: 2.801

3.  Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.

Authors:  L-L Liu; Y Jiang; L-N Wang; N Liu
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

4.  Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy.

Authors:  Grigorios T Sakellariou; Periklis Vounotrypidis; Charalampos Berberidis
Journal:  Clin Rheumatol       Date:  2006-08-19       Impact factor: 2.980

Review 5.  Corticosteroid therapy in IgA nephropathy.

Authors:  Jicheng Lv; Damin Xu; Vlado Perkovic; Xinxin Ma; David W Johnson; Mark Woodward; Adeera Levin; Hong Zhang; Haiyan Wang
Journal:  J Am Soc Nephrol       Date:  2012-04-26       Impact factor: 10.121

6.  Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients.

Authors:  Taro Misaki; Shuhei Naka; Keiko Kuroda; Ryota Nomura; Tempei Shiooka; Yoshitaka Naito; Yumiko Suzuki; Hideo Yasuda; Taisuke Isozaki; Kazuhiko Nakano
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

7.  Intermedin ameliorates IgA nephropathy by inhibition of oxidative stress and inflammation.

Authors:  Yanhong Wang; Jihua Tian; Haixiu Guo; Yang Mi; Ruijing Zhang; Rongshan Li
Journal:  Clin Exp Med       Date:  2015-04-28       Impact factor: 3.984

8.  IgA nephropathy presenting clinical features of poststreptococcal glomerulonephritis.

Authors:  Naila Al-Ruqeishi; Poothirikovil Venugopalan; Ibtisam El Nour; Anand Date
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

9.  Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).

Authors:  Yuko Shima; Koichi Nakanishi; Mayumi Sako; Mari Saito-Oba; Yuko Hamasaki; Hiroshi Hataya; Masataka Honda; Koichi Kamei; Kenji Ishikura; Shuichi Ito; Hiroshi Kaito; Ryojiro Tanaka; Kandai Nozu; Hidefumi Nakamura; Yasuo Ohashi; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2018-10-03       Impact factor: 3.714

10.  Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schonlein purpura.

Authors:  Roland Schmitt; Fredric Carlsson; Matthias Mörgelin; Ramesh Tati; Gunnar Lindahl; Diana Karpman
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.